Skin and hair Medicines Approved in the EU (EMA)

• 38medicines authorised in the EU (authorised now)

Each number has its full source under its own list below.

• 23Apr2025

  Vyjuvek

  Active substance: Beremagene geperpavec

  EMEA/H/C/006330
• 12Feb2025

  Nemluvio

  Active substance: nemolizumab

  EMEA/H/C/006149
• 19Sep2024

  Anzupgo

  Active substance: Delgocitinib

  EMEA/H/C/006109
• 16May2024

  Omlyclo

  Active substance: omalizumab

  EMEA/H/C/005958
• 16Nov2023

  Ebglyss

  Active substance: Lebrikizumab

  EMEA/H/C/005894
• 15Sep2023

  Litfulo

  Active substance: ritlecitinib tosilate

  EMEA/H/C/006025
• 19Apr2023

  Opzelura

  Active substance: ruxolitinib

  EMEA/H/C/005843
• 15Jul2022

  Ertapenem SUN

  EMEA/H/C/005815
• 9Dec2021

  Cibinqo

  Active substance: abrocitinib

  EMEA/H/C/005452
• 16Jul2021

  Klisyri

  Active substance: tirbanibulin

  EMEA/H/C/005183
• 17Jun2021

  Adtralza

  EMEA/H/C/005255
• 17Apr2020

  Tigecycline Accord

  Active substance: tigecycline

  EMEA/H/C/005114
• 16Dec2019

  Rinvoq

  Active substance: upadacitinib

  EMEA/H/C/004760
• 16Dec2019

  Quofenix

  Active substance: delafloxacin meglumine

  EMEA/H/C/004860
• 27Sep2019

  Nuceiva

  Active substance: Botulinum toxin type A

  EMEA/H/C/004587

Source: European Medicines Agency, Centrally authorised human medicines (EPAR), authorised now. Retrieved 12 Nov 2026.

• Aesthetics
• Infectious diseases
• Allergies
• Biologics and biosimilars
• Immune health
• Autoimmune diseases
• Bones and joints
• OTC medicines
• Antibiotics